Envision Legal
← More case law

Davis v Wilson: appeal dismissed over sandalwood valuations and financial reporting representations

17 November 2026WatchCourt decisionsDavis v Wilson [2026] FCAFC 142

The development

The Federal Court dismissed the appeal in Davis v Wilson on 17 November 2026. The representative proceedings concerned alleged overstatement of biological assets in financial reports through sandalwood plantation valuations under AASB 12 and AASB 141. The applicants did not establish their proposed counterfactual heartwood yield of 6 to 8 kg per tree. The valuation assumptions were not shown to be unreasonable. The judgment also addressed representations by directors and auditors concerning financial reports, with implications for financial reporting governance.

For directors’ declarations under s 295 of the Corporations Act 2001 (Cth), the Court held that an unqualified collective declaration conveyed that each approving director held the stated opinions. The issues included whether the first respondent personally made representations to the market and whether reasonable grounds existed, including reliance on internal expertise, the audit committee and the external auditor.

The Court also found a sufficient connection between audit opinions and services and company shares for s 1041H of the Corporations Act and ss 12BAB and 12DA of the Australian Securities and Investments Commission Act 2001 (Cth). An audit contravention was not established. Separately, the primary judge erred in construing the pleaded liability case: the particulars formed part of that case. Cross-appeals were allowed in part, and the remaining causation grounds did not require determination.

The briefing

Regulator or source
Federal Court
Type
Case · Court decisions
Subject matter
Commercial, corporate & consumer
Jurisdiction
Cth
Published
17 November 2026
Submissions close
No deadline
Reference
Davis v Wilson [2026] FCAFC 142
Priority
Watch

What it means for business

Boards approving financial reports may wish to consider whether their approval records capture each director’s basis for the opinions expressed in a s 295 declaration. The finding about collective declarations suggests that the collective form is not a substitute for considering each approving director’s stated opinions. Where biological asset valuations depend on predicted yields, governance processes could usefully document the assumptions and supporting expertise. Records of consideration by internal specialists, the audit committee and the external auditor may also assist in explaining the basis for approval. These are governance considerations, not new reporting obligations announced by the judgment.

Entry last reviewed 19 November 2026.

What does this mean for your business?

If this development touches your contracts, compliance or reporting, it may be worth a short conversation. Get in touch through our contact page and a senior lawyer will reply within one business day.

Request a fixed-fee scope

Regulatory alerts

Get the radar in your inbox.

A short email when something worth knowing lands. Pick the areas you care about and skip the rest.

Areas of interest

By subscribing you consent to receive these updates. Your address is used only for this purpose and you can unsubscribe at any time. See our privacy policy.

This register contains general information only and does not constitute legal advice. Envision Legal accepts no liability for any loss arising from reliance on this content. You should seek independent legal advice tailored to your specific circumstances. For enquiries, contact Envision Legal.

Send a briefFixed-fee quote